D. Stoll

Discipline

Linguistique (1) Education (1)

Type de document

Articles (8) Colloques et conférences (2) Autres (1)

Co-auteur

Date

Source

Mot-clé

Patients (7) Patients (7) Bone (6) risque (5) Risk (5) Population (5) Osteoporosis (5) Population (5) test (4) âge (4) Women (4) Vitamin D (4) Age (4) Age (4) Fracture (4) Treatment (3) Rheumatology (3) Values (3) Swiss (3) Scarcity (3) Management (3) Human beings (3) Fractures (3) Addition (3) Cholecalciferol (3) Women (3) Fractures (3) puits (2) mise sous écran protecteur (2) association (2)

Documents écrit par D. Stoll (11) | parle de D. Stoll (0)

Commentary to "Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials" (Galvano et al. J Bone Oncol 2019; 18:100252).
E. Gonzalez-Rodriguez et al.
Impact of a fracture liaison service on patient management after an osteoporotic fracture: the CHUV FLS.
B. Aubry-Rozier et al. (2018)
Raloxifene Has No Efficacy in Reducing the High Bone Turnover and the Risk of Spontaneous Vertebral Fractures after Denosumab Discontinuation.
E. Gonzalez-Rodriguez et al. (2018)
Can one or two high doses of oral vitamin D3 correct insufficiency in a non-supplemented rheumatologic population?
D. Stoll et al. (2013)
What was your fracture risk evaluated by FRAX(®) the day before your osteoporotic fracture?
B. Aubry-Rozier et al. (2013)
Changing the awareness of low vitamin D status in a rheumatology population: a pre/post-study.
D. Stoll et al. (2013)
Diffuse nesidioblastosis with hypoglycemia mimicking an insulinoma: a case report.
C. Ferrario et al. (2012)
TBS en routine clinique: propositions d'utilisation - L'apport de la texture osseuse dans la prise en charge des ostéoporoses
C. Cormier et al. (2012)
High prevalence of hypovitaminosis D in a Swiss rheumatology outpatient population.
D. Stoll et al. (2011)
A single high dose of oral vitamin D3 is insufficient to correct a deficiency in a rheumatologic population
D. Stoll et al. (2011)
IVA in addition to BMD can change the osteoporosis management in 25% of clinical routine patients
B. Aubry-Rozier et al. (2011)